| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | Rab GDP-dissociation inhibitor activity | 4.67e-05 | 2 | 137 | 2 | GO:0005093 | |
| GeneOntologyMolecularFunction | ethanolamine kinase activity | 2.78e-04 | 4 | 137 | 2 | GO:0004305 | |
| GeneOntologyMolecularFunction | cysteine-type peptidase activity | 3.66e-04 | 192 | 137 | 7 | GO:0008234 | |
| GeneOntologyBiologicalProcess | cilium assembly | DNHD1 CCP110 STK36 INTU AHI1 DYNC2H1 SYNE1 ZNF423 GDI2 KIAA0753 NPHP3 CELSR2 CPLANE1 | 6.14e-06 | 444 | 133 | 13 | GO:0060271 |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection assembly | DNHD1 CCP110 STK36 INTU AHI1 NCKAP1 DYNC2H1 SYNE1 ZNF423 GDI2 KIAA0753 TGFBR1 SLIT2 NPHP3 CELSR2 CPLANE1 | 6.76e-06 | 670 | 133 | 16 | GO:0120031 |
| GeneOntologyBiologicalProcess | cell projection assembly | DNHD1 CCP110 STK36 INTU AHI1 NCKAP1 DYNC2H1 SYNE1 ZNF423 GDI2 KIAA0753 TGFBR1 SLIT2 NPHP3 CELSR2 CPLANE1 | 8.91e-06 | 685 | 133 | 16 | GO:0030031 |
| GeneOntologyBiologicalProcess | cilium organization | DNHD1 CCP110 STK36 INTU AHI1 DYNC2H1 SYNE1 ZNF423 GDI2 KIAA0753 NPHP3 CELSR2 CPLANE1 | 1.29e-05 | 476 | 133 | 13 | GO:0044782 |
| GeneOntologyBiologicalProcess | cardiac septum development | 2.63e-05 | 134 | 133 | 7 | GO:0003279 | |
| GeneOntologyBiologicalProcess | epicardium morphogenesis | 4.13e-05 | 2 | 133 | 2 | GO:1905223 | |
| GeneOntologyBiologicalProcess | cardiac chamber development | 7.12e-05 | 212 | 133 | 8 | GO:0003205 | |
| GeneOntologyBiologicalProcess | regulation of plasma membrane bounded cell projection organization | TRIM46 CCP110 INTU AHI1 NCKAP1 SYNE1 PUM2 GDI1 GDI2 LRP8 TGFBR1 SLIT2 SLC39A12 P3H1 LRP1 CNR1 | 1.12e-04 | 846 | 133 | 16 | GO:0120035 |
| GeneOntologyBiologicalProcess | positive regulation of sprouting of injured axon | 1.23e-04 | 3 | 133 | 2 | GO:0048687 | |
| GeneOntologyBiologicalProcess | regulation of cell projection organization | TRIM46 CCP110 INTU AHI1 NCKAP1 SYNE1 PUM2 GDI1 GDI2 LRP8 TGFBR1 SLIT2 SLC39A12 P3H1 LRP1 CNR1 | 1.41e-04 | 863 | 133 | 16 | GO:0031344 |
| HumanPheno | Abnormal renal medulla morphology | 7.07e-06 | 62 | 40 | 6 | HP:0100957 | |
| HumanPheno | Nephronophthisis | 8.37e-06 | 37 | 40 | 5 | HP:0000090 | |
| HumanPheno | Duplication involving bones of the feet | 1.40e-05 | 147 | 40 | 8 | HP:0009136 | |
| HumanPheno | Foot polydactyly | 1.40e-05 | 147 | 40 | 8 | HP:0001829 | |
| HumanPheno | Hamartoma of tongue | 2.59e-05 | 23 | 40 | 4 | HP:0011802 | |
| HumanPheno | Central Y-shaped metacarpal | 7.09e-05 | 11 | 40 | 3 | HP:0006145 | |
| HumanPheno | Abdominal situs inversus | 9.73e-05 | 142 | 40 | 7 | HP:0003363 | |
| HumanPheno | Situs inversus totalis | 9.73e-05 | 142 | 40 | 7 | HP:0001696 | |
| HumanPheno | Abnormal spatial orientation of the cardiac segments | 9.73e-05 | 142 | 40 | 7 | HP:0011534 | |
| HumanPheno | Abnormality of abdominal situs | 9.73e-05 | 142 | 40 | 7 | HP:0011620 | |
| HumanPheno | Heterotaxy | 1.11e-04 | 145 | 40 | 7 | HP:0030853 | |
| HumanPheno | Hand polydactyly | INTU AHI1 DYNC2H1 NSD2 ZNF423 KIAA0753 TGFBR1 KIAA0825 CPLANE1 | 1.16e-04 | 254 | 40 | 9 | HP:0001161 |
| HumanPheno | Postaxial polydactyly | 1.26e-04 | 148 | 40 | 7 | HP:0100259 | |
| HumanPheno | Duplication of phalanx of hand | INTU AHI1 DYNC2H1 NSD2 ZNF423 KIAA0753 TGFBR1 KIAA0825 CPLANE1 | 1.27e-04 | 257 | 40 | 9 | HP:0009997 |
| HumanPheno | Duplication of hand bones | INTU AHI1 DYNC2H1 NSD2 ZNF423 KIAA0753 TGFBR1 KIAA0825 CPLANE1 | 1.31e-04 | 258 | 40 | 9 | HP:0004275 |
| HumanPheno | Duplication of bones involving the upper extremities | INTU AHI1 DYNC2H1 NSD2 ZNF423 KIAA0753 TGFBR1 KIAA0825 CPLANE1 | 1.31e-04 | 258 | 40 | 9 | HP:0009142 |
| HumanPheno | Y-shaped metacarpals | 1.91e-04 | 15 | 40 | 3 | HP:0006042 | |
| HumanPheno | Aplasia/Hypoplasia of the retina | STK36 AHI1 ZNF423 PEX1 APOB LYST GPR179 FGF17 EYS NPHP3 HACE1 AHR | 1.96e-04 | 478 | 40 | 12 | HP:0008061 |
| HumanPheno | Dextrocardia | 1.98e-04 | 159 | 40 | 7 | HP:0001651 | |
| HumanPheno | Abnormal anatomic location of the heart | 2.06e-04 | 160 | 40 | 7 | HP:0004307 | |
| HumanPheno | Polydactyly | INTU AHI1 DYNC2H1 NSD2 ZNF423 KIAA0753 TGFBR1 NPHP3 KIAA0825 CPLANE1 | 2.14e-04 | 340 | 40 | 10 | HP:0010442 |
| HumanPheno | Molar tooth sign on MRI | 2.43e-04 | 40 | 40 | 4 | HP:0002419 | |
| HumanPheno | Neoplasm of the tongue | 2.94e-04 | 42 | 40 | 4 | HP:0100648 | |
| HumanPheno | Retinal dystrophy | STK36 AHI1 ZNF423 PEX1 APOB GPR179 FGF17 EYS NPHP3 HACE1 AHR | 4.13e-04 | 441 | 40 | 11 | HP:0000556 |
| Domain | EGF | MUC13 TECTA ITGB5 GPR179 LRP8 SLIT2 NELL1 MFGE8 EYS THBS3 CELSR2 LRP1 PLAU NOTCH2 NOTCH4 | 1.46e-10 | 235 | 134 | 15 | SM00181 |
| Domain | Growth_fac_rcpt_ | MUC13 HTRA4 GPR179 LRP8 NELL1 EYS THBS3 CELSR2 LRP1 NOTCH2 NOTCH4 CCN3 | 1.32e-09 | 156 | 134 | 12 | IPR009030 |
| Domain | EGF | 2.45e-08 | 126 | 134 | 10 | PF00008 | |
| Domain | EGF-like_dom | MUC13 TECTA LRP8 SLIT2 NELL1 MFGE8 EYS THBS3 CELSR2 LRP1 PLAU NOTCH2 NOTCH4 | 2.91e-08 | 249 | 134 | 13 | IPR000742 |
| Domain | EGF_1 | MUC13 ITGB5 LRP8 SLIT2 NELL1 MFGE8 EYS THBS3 CELSR2 LRP1 PLAU NOTCH2 NOTCH4 | 3.85e-08 | 255 | 134 | 13 | PS00022 |
| Domain | EGF-like_CS | MUC13 ITGB5 LRP8 SLIT2 NELL1 MFGE8 EYS THBS3 CELSR2 LRP1 PLAU NOTCH2 NOTCH4 | 5.07e-08 | 261 | 134 | 13 | IPR013032 |
| Domain | EGF_2 | MUC13 ITGB5 LRP8 SLIT2 NELL1 MFGE8 EYS THBS3 CELSR2 LRP1 PLAU NOTCH2 NOTCH4 | 6.05e-08 | 265 | 134 | 13 | PS01186 |
| Domain | EGF_3 | MUC13 LRP8 SLIT2 NELL1 MFGE8 EYS THBS3 CELSR2 LRP1 PLAU NOTCH2 NOTCH4 | 1.30e-07 | 235 | 134 | 12 | PS50026 |
| Domain | EGF_CA | 2.36e-07 | 122 | 134 | 9 | SM00179 | |
| Domain | EGF-like_Ca-bd_dom | 2.72e-07 | 124 | 134 | 9 | IPR001881 | |
| Domain | EGF_Ca-bd_CS | 4.81e-07 | 97 | 134 | 8 | IPR018097 | |
| Domain | EGF_CA | 5.63e-07 | 99 | 134 | 8 | PS01187 | |
| Domain | ASX_HYDROXYL | 6.08e-07 | 100 | 134 | 8 | PS00010 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 9.51e-07 | 106 | 134 | 8 | IPR000152 | |
| Domain | hEGF | 1.52e-06 | 28 | 134 | 5 | PF12661 | |
| Domain | - | TRIM46 TRAF6 TRIM25 USP22 TRIM51 NSD2 ZNF423 ZNF521 DIDO1 TRIM24 USP44 PCGF6 SCAF11 | 2.13e-05 | 449 | 134 | 13 | 3.30.40.10 |
| Domain | Znf_RING/FYVE/PHD | TRIM46 TRAF6 TRIM25 USP22 TRIM51 NSD2 ZNF423 ZNF521 DIDO1 TRIM24 USP44 PCGF6 SCAF11 | 2.68e-05 | 459 | 134 | 13 | IPR013083 |
| Domain | EGF_CA | 3.58e-05 | 86 | 134 | 6 | PF07645 | |
| Domain | Pept_M12B_GON-ADAMTSs | 5.11e-05 | 2 | 134 | 2 | IPR012314 | |
| Domain | GON | 5.11e-05 | 2 | 134 | 2 | PS51046 | |
| Domain | RabGDI | 5.11e-05 | 2 | 134 | 2 | IPR000806 | |
| Domain | Pumilio_RNA-bd | 5.11e-05 | 2 | 134 | 2 | IPR033712 | |
| Domain | GON | 5.11e-05 | 2 | 134 | 2 | PF08685 | |
| Domain | Laminin_G | 5.96e-05 | 58 | 134 | 5 | IPR001791 | |
| Domain | USP_CS | 1.11e-04 | 66 | 134 | 5 | IPR018200 | |
| Domain | USP_1 | 1.47e-04 | 70 | 134 | 5 | PS00972 | |
| Domain | PUF | 1.53e-04 | 3 | 134 | 2 | PF00806 | |
| Domain | PUM_HD | 1.53e-04 | 3 | 134 | 2 | PS50303 | |
| Domain | PUM-HD | 1.53e-04 | 3 | 134 | 2 | IPR033133 | |
| Domain | VWFC_2 | 1.55e-04 | 38 | 134 | 4 | PS50184 | |
| Domain | VWC | 1.55e-04 | 38 | 134 | 4 | SM00214 | |
| Domain | UCH | 1.57e-04 | 71 | 134 | 5 | PF00443 | |
| Domain | USP_2 | 1.57e-04 | 71 | 134 | 5 | PS00973 | |
| Domain | USP_3 | 1.68e-04 | 72 | 134 | 5 | PS50235 | |
| Domain | USP_dom | 1.68e-04 | 72 | 134 | 5 | IPR028889 | |
| Domain | Peptidase_C19_UCH | 1.68e-04 | 72 | 134 | 5 | IPR001394 | |
| Domain | Znf_RING_CS | 1.76e-04 | 163 | 134 | 7 | IPR017907 | |
| Domain | ConA-like_dom | 1.85e-04 | 219 | 134 | 8 | IPR013320 | |
| Domain | Laminin_G_2 | 1.89e-04 | 40 | 134 | 4 | PF02210 | |
| Domain | VWF_dom | 2.30e-04 | 42 | 134 | 4 | IPR001007 | |
| Domain | CTCK_1 | 2.72e-04 | 18 | 134 | 3 | PS01185 | |
| Domain | LamG | 2.75e-04 | 44 | 134 | 4 | SM00282 | |
| Domain | Fumarylacetoacetase_C-rel | 3.04e-04 | 4 | 134 | 2 | IPR011234 | |
| Domain | Notch | 3.04e-04 | 4 | 134 | 2 | IPR008297 | |
| Domain | NODP | 3.04e-04 | 4 | 134 | 2 | PF07684 | |
| Domain | FAA_hydrolase | 3.04e-04 | 4 | 134 | 2 | PF01557 | |
| Domain | Notch_NODP_dom | 3.04e-04 | 4 | 134 | 2 | IPR011656 | |
| Domain | - | 3.04e-04 | 4 | 134 | 2 | 3.90.850.10 | |
| Domain | PUM | 3.04e-04 | 4 | 134 | 2 | PS50302 | |
| Domain | GDI | 3.04e-04 | 4 | 134 | 2 | PF00996 | |
| Domain | Pumilio_RNA-bd_rpt | 3.04e-04 | 4 | 134 | 2 | IPR001313 | |
| Domain | Notch_NOD_dom | 3.04e-04 | 4 | 134 | 2 | IPR010660 | |
| Domain | GDP_dissociation_inhibitor | 3.04e-04 | 4 | 134 | 2 | IPR018203 | |
| Domain | NOD | 3.04e-04 | 4 | 134 | 2 | PF06816 | |
| Domain | Pumilio | 3.04e-04 | 4 | 134 | 2 | SM00025 | |
| Domain | NOD | 3.04e-04 | 4 | 134 | 2 | SM01338 | |
| Domain | NODP | 3.04e-04 | 4 | 134 | 2 | SM01339 | |
| Domain | VWC_out | 3.22e-04 | 19 | 134 | 3 | SM00215 | |
| Domain | RING | 3.60e-04 | 305 | 134 | 9 | SM00184 | |
| Domain | CT | 5.03e-04 | 22 | 134 | 3 | SM00041 | |
| Domain | LNR | 5.04e-04 | 5 | 134 | 2 | PS50258 | |
| Domain | Znf_RING | 5.82e-04 | 326 | 134 | 9 | IPR001841 | |
| Domain | - | 6.10e-04 | 95 | 134 | 5 | 2.60.120.200 | |
| Domain | Cys_knot_C | 7.40e-04 | 25 | 134 | 3 | IPR006207 | |
| Domain | CTCK_2 | 7.40e-04 | 25 | 134 | 3 | PS01225 | |
| Domain | ARM-type_fold | 7.69e-04 | 339 | 134 | 9 | IPR016024 | |
| Domain | Notch_dom | 1.05e-03 | 7 | 134 | 2 | IPR000800 | |
| Domain | Notch | 1.05e-03 | 7 | 134 | 2 | PF00066 | |
| Domain | NL | 1.05e-03 | 7 | 134 | 2 | SM00004 | |
| Domain | zf-C3HC4 | 1.15e-03 | 223 | 134 | 7 | PF00097 | |
| Domain | ZF_RING_1 | 1.21e-03 | 291 | 134 | 8 | PS00518 | |
| Domain | Zinc_finger_PHD-type_CS | 1.22e-03 | 65 | 134 | 4 | IPR019786 | |
| Domain | ZF_RING_2 | 1.41e-03 | 298 | 134 | 8 | PS50089 | |
| Domain | - | 1.70e-03 | 71 | 134 | 4 | 4.10.45.10 | |
| Domain | VWFC_1 | 2.17e-03 | 36 | 134 | 3 | PS01208 | |
| Domain | Znf_PHD-finger | 2.51e-03 | 79 | 134 | 4 | IPR019787 | |
| Domain | LAM_G_DOMAIN | 2.54e-03 | 38 | 134 | 3 | PS50025 | |
| Domain | Laminin_G_1 | 2.69e-03 | 11 | 134 | 2 | PF00054 | |
| Domain | Znf_B-box | 2.75e-03 | 81 | 134 | 4 | IPR000315 | |
| Domain | LDLR_class-A_CS | 2.94e-03 | 40 | 134 | 3 | IPR023415 | |
| Domain | C8 | 3.22e-03 | 12 | 134 | 2 | PF08742 | |
| Domain | TIL | 3.22e-03 | 12 | 134 | 2 | PF01826 | |
| Domain | Unchr_dom_Cys-rich | 3.78e-03 | 13 | 134 | 2 | IPR014853 | |
| Domain | C8 | 3.78e-03 | 13 | 134 | 2 | SM00832 | |
| Domain | Ldl_recept_a | 4.11e-03 | 45 | 134 | 3 | PF00057 | |
| Domain | - | 4.38e-03 | 46 | 134 | 3 | 4.10.400.10 | |
| Domain | Dynein_HC_stalk | 4.39e-03 | 14 | 134 | 2 | IPR024743 | |
| Domain | Dynein_heavy_dom-2 | 4.39e-03 | 14 | 134 | 2 | IPR013602 | |
| Domain | Znf_UBP | 4.39e-03 | 14 | 134 | 2 | IPR001607 | |
| Domain | DHC_N2 | 4.39e-03 | 14 | 134 | 2 | PF08393 | |
| Domain | TIL_dom | 4.39e-03 | 14 | 134 | 2 | IPR002919 | |
| Domain | zf-UBP | 4.39e-03 | 14 | 134 | 2 | PF02148 | |
| Domain | MT | 4.39e-03 | 14 | 134 | 2 | PF12777 | |
| Domain | Ldl_recept_b | 4.39e-03 | 14 | 134 | 2 | PF00058 | |
| Domain | LDLRB | 4.39e-03 | 14 | 134 | 2 | PS51120 | |
| Domain | ZF_UBP | 4.39e-03 | 14 | 134 | 2 | PS50271 | |
| Domain | Ank_2 | 4.60e-03 | 215 | 134 | 6 | PF12796 | |
| Domain | LDLRA_1 | 4.93e-03 | 48 | 134 | 3 | PS01209 | |
| Domain | DHC_fam | 5.05e-03 | 15 | 134 | 2 | IPR026983 | |
| Domain | Dynein_heavy | 5.05e-03 | 15 | 134 | 2 | PF03028 | |
| Pathway | REACTOME_UB_SPECIFIC_PROCESSING_PROTEASES | 1.35e-05 | 191 | 106 | 9 | MM15289 | |
| Pathway | REACTOME_UB_SPECIFIC_PROCESSING_PROTEASES | 4.28e-05 | 221 | 106 | 9 | M27578 | |
| Pathway | REACTOME_DEUBIQUITINATION | CCP110 USP18 TRAF6 TRIM25 USP22 USP19 USP44 TGFBR1 USP4 SMURF2 | 8.38e-05 | 299 | 106 | 10 | M27574 |
| Pathway | KEGG_MEDICUS_PATHOGEN_HPV_E6_TO_NOTCH_SIGNALING_PATHWAY_N00382 | 1.12e-04 | 13 | 106 | 3 | M47534 | |
| Pathway | WP_KENNEDY_PATHWAY | 1.42e-04 | 14 | 106 | 3 | MM15980 | |
| Pathway | WP_KENNEDY_PATHWAY_FROM_SPHINGOLIPIDS | 1.42e-04 | 14 | 106 | 3 | M39620 | |
| Pathway | REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS | 1.56e-04 | 68 | 106 | 5 | M27303 | |
| Pathway | REACTOME_DEUBIQUITINATION | 1.57e-04 | 262 | 106 | 9 | MM15286 | |
| Pathway | PID_INTEGRIN5_PATHWAY | 2.60e-04 | 17 | 106 | 3 | M212 | |
| Pathway | WP_JOUBERT_SYNDROME | 2.64e-04 | 76 | 106 | 5 | M39835 | |
| Pubmed | 1.19e-06 | 6 | 137 | 3 | 29228365 | ||
| Pubmed | STK36 TRPC4AP WAPL DYNC2H1 CCDC186 SYNE1 PEX1 DIDO1 APOB MUC13 TRIM24 GDI2 PUM1 NOTCH4 | 1.83e-06 | 754 | 137 | 14 | 35906200 | |
| Pubmed | USP4 is regulated by AKT phosphorylation and directly deubiquitylates TGF-β type I receptor. | 3.30e-06 | 8 | 137 | 3 | 22706160 | |
| Pubmed | KIAA0408 ZFAT UACA SYNE1 BIRC6 ITGB5 PCGF6 PARP4 NPHP3 ADAMTS9 NOTCH2 | 4.78e-06 | 497 | 137 | 11 | 23414517 | |
| Pubmed | 5.16e-06 | 63 | 137 | 5 | 23105109 | ||
| Pubmed | INTU NCKAP1 SYNE1 ZNF423 PUM2 ZYG11B USP19 PCDH19 PUM1 PCDH10 | 5.29e-06 | 407 | 137 | 10 | 12693553 | |
| Pubmed | AHI1 WAPL SALL3 CTC1 PEX1 DIDO1 APOB KIAA0753 TGFBR1 NPHP3 NFX1 TMEM131L ZMYM1 CPLANE1 PUM1 ESPL1 | 6.17e-06 | 1084 | 137 | 16 | 11544199 | |
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | LRWD1 TRIM25 UACA PUM2 SLIT2 PCGF6 PARP4 NFX1 UNK HELZ ZMYM1 PUM1 ESPL1 | 6.23e-06 | 724 | 137 | 13 | 36232890 |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | STK36 LRWD1 CTC1 NSD2 ZNF236 BIRC6 LYST ITGB5 AATK CELSR2 NFX1 TLN2 PUM1 ESPL1 SMURF2 NOTCH2 | 7.84e-06 | 1105 | 137 | 16 | 35748872 |
| Pubmed | 9.64e-06 | 11 | 137 | 3 | 22379998 | ||
| Pubmed | 1.02e-05 | 124 | 137 | 6 | 20850016 | ||
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | LRWD1 WAPL UACA PUM2 DIDO1 USP19 PASK UNK HELZ TLN2 SCAF11 ESPL1 NOTCH2 | 1.26e-05 | 774 | 137 | 13 | 15302935 |
| Pubmed | MKRN2 Physically Interacts with GLE1 to Regulate mRNA Export and Zebrafish Retinal Development. | 1.32e-05 | 358 | 137 | 9 | 32460013 | |
| Pubmed | [Genetic testing and prenatal diagnosis for two families affected with Joubert syndrome]. | 1.54e-05 | 2 | 137 | 2 | 32335874 | |
| Pubmed | 1.54e-05 | 2 | 137 | 2 | 11532344 | ||
| Pubmed | Differential glycosylation regulates processing of lipoprotein receptors by gamma-secretase. | 1.54e-05 | 2 | 137 | 2 | 12871934 | |
| Pubmed | Essential role for MFG-E8 as ligand for alphavbeta5 integrin in diurnal retinal phagocytosis. | 1.54e-05 | 2 | 137 | 2 | 17620600 | |
| Pubmed | 1.54e-05 | 2 | 137 | 2 | 12459267 | ||
| Pubmed | Identification of diverse target RNAs that are functionally regulated by human Pumilio proteins. | 1.54e-05 | 2 | 137 | 2 | 29165587 | |
| Pubmed | 1.54e-05 | 2 | 137 | 2 | 30335615 | ||
| Pubmed | 1.54e-05 | 2 | 137 | 2 | 35507203 | ||
| Pubmed | 1.54e-05 | 2 | 137 | 2 | 26517885 | ||
| Pubmed | 1.54e-05 | 2 | 137 | 2 | 12667987 | ||
| Pubmed | A Quantitative and Predictive Model for RNA Binding by Human Pumilio Proteins. | 1.54e-05 | 2 | 137 | 2 | 31078383 | |
| Pubmed | 1.54e-05 | 2 | 137 | 2 | 32753408 | ||
| Pubmed | 1.54e-05 | 2 | 137 | 2 | 32437472 | ||
| Pubmed | 1.54e-05 | 2 | 137 | 2 | 7585614 | ||
| Pubmed | 1.54e-05 | 2 | 137 | 2 | 12393497 | ||
| Pubmed | 1.54e-05 | 2 | 137 | 2 | 32316190 | ||
| Pubmed | 1.54e-05 | 2 | 137 | 2 | 19729411 | ||
| Pubmed | Differential expression of murine CGI-105 gene in 3T3-L1 cells by adrenocorticotropic hormones. | 1.54e-05 | 2 | 137 | 2 | 15774318 | |
| Pubmed | Overexpression of a mammalian ethanolamine-specific kinase accelerates the CDP-ethanolamine pathway. | 1.54e-05 | 2 | 137 | 2 | 11044454 | |
| Pubmed | 1.54e-05 | 2 | 137 | 2 | 36646950 | ||
| Pubmed | The expression of low density lipoprotein receptor-related protein in colorectal carcinoma. | 1.54e-05 | 2 | 137 | 2 | 17203175 | |
| Pubmed | 1.54e-05 | 2 | 137 | 2 | 12771951 | ||
| Pubmed | Alternate modes of cognate RNA recognition by human PUMILIO proteins. | 1.54e-05 | 2 | 137 | 2 | 21397187 | |
| Pubmed | 1.54e-05 | 2 | 137 | 2 | 16807059 | ||
| Pubmed | 1.54e-05 | 2 | 137 | 2 | 12514189 | ||
| Pubmed | Smurf2 participates in human trophoblast cell invasion by inhibiting TGF-beta type I receptor. | 1.54e-05 | 2 | 137 | 2 | 19255252 | |
| Pubmed | UPA promotes lipid-loaded vascular smooth muscle cell migration through LRP-1. | 1.54e-05 | 2 | 137 | 2 | 23812296 | |
| Pubmed | PUMILIO proteins promote colorectal cancer growth via suppressing p21. | 1.54e-05 | 2 | 137 | 2 | 35338151 | |
| Pubmed | 1.54e-05 | 2 | 137 | 2 | 22262844 | ||
| Pubmed | 1.54e-05 | 2 | 137 | 2 | 23587900 | ||
| Pubmed | 1.54e-05 | 2 | 137 | 2 | 30194441 | ||
| Pubmed | 1.54e-05 | 2 | 137 | 2 | 18776931 | ||
| Pubmed | 1.54e-05 | 2 | 137 | 2 | 25622187 | ||
| Pubmed | 1.54e-05 | 2 | 137 | 2 | 20643108 | ||
| Pubmed | 1.78e-05 | 81 | 137 | 5 | 12838346 | ||
| Pubmed | Temporal patterning of apical progenitors and their daughter neurons in the developing neocortex. | 1.89e-05 | 82 | 137 | 5 | 31073041 | |
| Pubmed | CCP110 STK36 UACA DYNC2H1 BIRC6 KIAA0753 PARP4 NPHP3 ADAMTS9 ANKRD24 | 2.76e-05 | 493 | 137 | 10 | 15368895 | |
| Pubmed | USP53 plays an antitumor role in hepatocellular carcinoma through deubiquitination of cytochrome c. | 2.96e-05 | 90 | 137 | 5 | 35654790 | |
| Pubmed | INTU WAPL ATXN7L2 USP22 UACA NSD2 PEX1 TRIM24 SLIT2 PASK PCDH19 LRP1 AHR HELZ NOTCH2 | 3.62e-05 | 1116 | 137 | 15 | 31753913 | |
| Pubmed | 4.61e-05 | 3 | 137 | 2 | 1971301 | ||
| Pubmed | Antagonistic and cooperative AGO2-PUM interactions in regulating mRNAs. | 4.61e-05 | 3 | 137 | 2 | 30333515 | |
| Pubmed | 4.61e-05 | 3 | 137 | 2 | 2627199 | ||
| Pubmed | 4.61e-05 | 3 | 137 | 2 | 26240314 | ||
| Pubmed | 4.61e-05 | 3 | 137 | 2 | 25885904 | ||
| Pubmed | 4.61e-05 | 3 | 137 | 2 | 17974965 | ||
| Pubmed | Differential expression of Notch genes in human osteoblastic cells. | 4.61e-05 | 3 | 137 | 2 | 11836628 | |
| Pubmed | Integrin-dependent functions of the angiogenic inducer NOV (CCN3): implication in wound healing. | 4.61e-05 | 3 | 137 | 2 | 15611078 | |
| Pubmed | A novel function of human Pumilio proteins in cytoplasmic sensing of viral infection. | 4.61e-05 | 3 | 137 | 2 | 25340845 | |
| Pubmed | Noncoding RNA NORAD Regulates Genomic Stability by Sequestering PUMILIO Proteins. | 4.61e-05 | 3 | 137 | 2 | 26724866 | |
| Pubmed | 4.61e-05 | 3 | 137 | 2 | 22029577 | ||
| Pubmed | 4.61e-05 | 3 | 137 | 2 | 21540184 | ||
| Pubmed | A universal metabolite repair enzyme removes a strong inhibitor of the TCA cycle. | 4.61e-05 | 3 | 137 | 2 | 38287013 | |
| Pubmed | 4.61e-05 | 3 | 137 | 2 | 11823422 | ||
| Pubmed | Notch signaling: cell fate control and signal integration in development. | 4.61e-05 | 3 | 137 | 2 | 10221902 | |
| Pubmed | 4.61e-05 | 3 | 137 | 2 | 26807171 | ||
| Pubmed | 4.61e-05 | 3 | 137 | 2 | 31173246 | ||
| Pubmed | TRIM25 regulates oxaliplatin resistance in colorectal cancer by promoting EZH2 stability. | 4.61e-05 | 3 | 137 | 2 | 33966039 | |
| Pubmed | 4.61e-05 | 3 | 137 | 2 | 24891617 | ||
| Pubmed | 4.61e-05 | 3 | 137 | 2 | 36994542 | ||
| Pubmed | Human Pumilio proteins directly bind the CCR4-NOT deadenylase complex to regulate the transcriptome. | 4.61e-05 | 3 | 137 | 2 | 33397688 | |
| Pubmed | 4.61e-05 | 3 | 137 | 2 | 27157388 | ||
| Pubmed | Involvement of the Apoer2 and Lrp1 receptors in mediating the pathological effects of ApoE4 in vivo. | 4.61e-05 | 3 | 137 | 2 | 24251389 | |
| Pubmed | Identification and characterization of three members of a novel subclass of protocadherins. | 4.61e-05 | 3 | 137 | 2 | 11549318 | |
| Pubmed | ZNF423 and ZNF521: EBF1 Antagonists of Potential Relevance in B-Lymphoid Malignancies. | 4.61e-05 | 3 | 137 | 2 | 26788497 | |
| Pubmed | Mfge8 regulates enterocyte lipid storage by promoting enterocyte triglyceride hydrolase activity. | 4.61e-05 | 3 | 137 | 2 | 27812539 | |
| Pubmed | 4.61e-05 | 3 | 137 | 2 | 22566632 | ||
| Pubmed | 4.61e-05 | 3 | 137 | 2 | 24753090 | ||
| Pubmed | RanBPM interacts with TβRI, TRAF6 and curbs TGF induced nuclear accumulation of TβRI. | 4.61e-05 | 3 | 137 | 2 | 24103590 | |
| Pubmed | 4.61e-05 | 3 | 137 | 2 | 35853811 | ||
| Pubmed | PUMILIO/FOXP1 signaling drives expansion of hematopoietic stem/progenitor and leukemia cells. | 4.61e-05 | 3 | 137 | 2 | 28232582 | |
| Pubmed | 4.61e-05 | 3 | 137 | 2 | 7543319 | ||
| Pubmed | 4.61e-05 | 3 | 137 | 2 | 22624557 | ||
| Pubmed | Autoregulation of insulin receptor signaling through MFGE8 and the αvβ5 integrin. | 4.61e-05 | 3 | 137 | 2 | 33903257 | |
| Pubmed | 4.61e-05 | 3 | 137 | 2 | 21629263 | ||
| Pubmed | 4.61e-05 | 3 | 137 | 2 | 7513052 | ||
| Pubmed | 4.61e-05 | 3 | 137 | 2 | 38427913 | ||
| Pubmed | 4.61e-05 | 3 | 137 | 2 | 16459332 | ||
| Pubmed | 4.61e-05 | 3 | 137 | 2 | 37169079 | ||
| Pubmed | 4.61e-05 | 3 | 137 | 2 | 31758376 | ||
| Pubmed | 4.61e-05 | 3 | 137 | 2 | 35017630 | ||
| Pubmed | 4.61e-05 | 3 | 137 | 2 | 12807892 | ||
| Pubmed | PTP1B mediates the inhibitory effect of MFGE8 on insulin signaling through the β5 integrin. | 4.61e-05 | 3 | 137 | 2 | 38199575 | |
| Pubmed | 4.61e-05 | 3 | 137 | 2 | 22345517 | ||
| Pubmed | 4.67e-05 | 18 | 137 | 3 | 30410068 | ||
| Pubmed | TRAF6 WAPL SYNE1 ZNF423 ZNF521 GDI1 NELL1 MFGE8 GTF3A ADAMTS9 TSPAN7 LRP1 TLN2 ANKRD24 SMURF2 KLHL4 | 4.89e-05 | 1285 | 137 | 16 | 35914814 | |
| Pubmed | Congenital Hepatic Fibrosis Overview ─ RETIRED CHAPTER, FOR HISTORICAL REFERENCE ONLY | 5.39e-05 | 52 | 137 | 4 | 20301743 | |
| Pubmed | 5.80e-05 | 335 | 137 | 8 | 15741177 | ||
| Interaction | CNOT9 interactions | CCP110 PUM2 BIRC6 KIAA0753 CCNF PASK PCGF6 AATK TMEM131L UNK HELZ PUM1 | 4.76e-08 | 231 | 134 | 12 | int:CNOT9 |
| Interaction | ZNF287 interactions | 2.88e-06 | 60 | 134 | 6 | int:ZNF287 | |
| Interaction | MAP3K7 interactions | USP18 TRAF6 TRIM25 GDI2 USP19 CCNF TGFBR1 THBS3 AATK NFX1 USP4 NOTCH4 | 9.07e-06 | 380 | 134 | 12 | int:MAP3K7 |
| GeneFamily | Ubiquitin specific peptidases | 1.11e-05 | 56 | 95 | 5 | 366 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | ZNF717 ZFAT SALL3 ZNF484 ZNF175 ZNF423 ZNF521 ZNF236 ZBTB49 GTF3A ZNF394 ZNF541 | 3.74e-04 | 718 | 95 | 12 | 28 |
| GeneFamily | Ring finger proteins | 6.17e-04 | 275 | 95 | 7 | 58 | |
| GeneFamily | PHD finger proteins | 1.29e-03 | 90 | 95 | 4 | 88 | |
| GeneFamily | Ring finger proteins|Tripartite motif containing|ARF GTPase family | 1.58e-03 | 95 | 95 | 4 | 59 | |
| GeneFamily | Ankyrin repeat domain containing | 1.74e-03 | 242 | 95 | 6 | 403 | |
| GeneFamily | Non-clustered protocadherins | 1.74e-03 | 12 | 95 | 2 | 21 | |
| GeneFamily | Low density lipoprotein receptors | 2.05e-03 | 13 | 95 | 2 | 634 | |
| GeneFamily | ADAM metallopeptidases with thrombospondin type 1 motif | 4.41e-03 | 19 | 95 | 2 | 50 | |
| GeneFamily | CD molecules|Mucins | 5.38e-03 | 21 | 95 | 2 | 648 | |
| Coexpression | MATZUK_SPERMATOZOA | 2.36e-06 | 114 | 137 | 7 | M1833 | |
| Coexpression | MATZUK_SPERMATOZOA | 2.65e-06 | 116 | 137 | 7 | MM1236 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 7.70e-06 | 191 | 137 | 8 | MM17059 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 9.30e-06 | 196 | 137 | 8 | M3008 | |
| Coexpression | GSE41867_DAY8_EFFECTOR_VS_DAY30_MEMORY_CD8_TCELL_LCMV_ARMSTRONG_DN | 1.08e-05 | 200 | 137 | 8 | M9484 | |
| Coexpression | GSE37532_TREG_VS_TCONV_PPARG_KO_CD4_TCELL_FROM_LN_UP | 1.08e-05 | 200 | 137 | 8 | M8959 | |
| Coexpression | NABA_MATRISOME | MUC13 HTRA4 TECTA FGF17 SLIT2 NELL1 MFGE8 THBS3 TINAG SERPINB9 ADAMTS9 OTOGL P3H1 ADAMTS20 PLAU MUC2 CCN3 | 2.12e-05 | 1008 | 137 | 17 | MM17056 |
| Coexpression | NABA_MATRISOME | MUC13 HTRA4 TECTA FGF17 SLIT2 NELL1 MFGE8 EYS THBS3 TINAG SERPINB9 ADAMTS9 P3H1 ADAMTS20 PLAU MUC2 CCN3 | 2.65e-05 | 1026 | 137 | 17 | M5889 |
| Coexpression | FAN_EMBRYONIC_CTX_EX_4_EXCITATORY_NEURON | 2.78e-05 | 166 | 137 | 7 | M39026 | |
| Coexpression | LAZARO_GENETIC_MOUSE_MODEL_HIGH_GRADE_SMALL_CELL_NEUROENDOCRINE_LUNG_CARCINOMA_UP | CCP110 AHI1 CTC1 NSD2 FXYD6P3 CHN2 CDCA2 PASK PCGF6 CELSR2 UNC79 CCN3 PCYT1B | 6.05e-05 | 680 | 137 | 13 | MM456 |
| Coexpression | GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_TURQUOISE_UP | 7.59e-05 | 83 | 137 | 5 | M15537 | |
| Coexpression | GSE3982_DC_VS_NKCELL_DN | 8.22e-05 | 197 | 137 | 7 | M5480 | |
| Coexpression | GSE17721_CTRL_VS_PAM3CSK4_2H_BMDC_UP | 8.75e-05 | 199 | 137 | 7 | M3733 | |
| Coexpression | GSE15330_HSC_VS_LYMPHOID_PRIMED_MULTIPOTENT_PROGENITOR_UP | 9.03e-05 | 200 | 137 | 7 | M7018 | |
| Coexpression | GSE15735_2H_VS_12H_HDAC_INHIBITOR_TREATED_CD4_TCELL_DN | 9.03e-05 | 200 | 137 | 7 | M7162 | |
| Coexpression | GSE17721_0.5H_VS_24H_CPG_BMDC_DN | 9.03e-05 | 200 | 137 | 7 | M4129 | |
| Coexpression | GSE6674_PL2_3_VS_ANTI_IGM_AND_CPG_STIM_BCELL_DN | 9.03e-05 | 200 | 137 | 7 | M6943 | |
| Coexpression | NABA_CORE_MATRISOME | 9.09e-05 | 270 | 137 | 8 | MM17057 | |
| Coexpression | BCAT_BILD_ET_AL_DN | 9.83e-05 | 46 | 137 | 4 | M2702 | |
| Coexpression | NABA_CORE_MATRISOME | 1.03e-04 | 275 | 137 | 8 | M5884 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.01e-09 | 184 | 137 | 9 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.01e-09 | 184 | 137 | 9 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.01e-09 | 184 | 137 | 9 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | Children_(3_yrs)-Endothelial|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.67e-07 | 195 | 137 | 8 | 094cf6591daa5ffad36e44122b6f524a3a34c2fd | |
| ToppCell | Control-Endothelial-Endothelial-Vein|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.80e-06 | 186 | 137 | 7 | 92092f11ecce22c14f244e42c499af0822977e6f | |
| ToppCell | COVID-19-Endothelial_cells-Pulmonary_venous_endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 1.87e-06 | 187 | 137 | 7 | 2d20193a6cacdfa4877457c97b0077408942186c | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Gen_Cap|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.30e-06 | 193 | 137 | 7 | 6e1982d089a9de628e6006d23ff78a223fbd9f47 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Gen_Cap|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.30e-06 | 193 | 137 | 7 | af5108260783e69a7d67896c5bf64f862525926d | |
| ToppCell | Control-Endothelial-Endothelial-Gen_Cap|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.30e-06 | 193 | 137 | 7 | e1d546165dcc2392f540162206852c4717d7306f | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Gen_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.38e-06 | 194 | 137 | 7 | 0b9cd96fa0b616da7cc90e92ff71157e9bba518f | |
| ToppCell | Adult-Endothelial|Adult / Lineage, Cell type, age group and donor | 2.38e-06 | 194 | 137 | 7 | 963b3fbee0575af8379baa397ace65949eaf34f7 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.47e-06 | 195 | 137 | 7 | 5c86fddd6d0530beecf45ea5ba6b823123847696 | |
| ToppCell | Parenchymal-NucSeq-Endothelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.82e-06 | 199 | 137 | 7 | a4a9a1c2a34b5a8318a55d1211d6c8661ca9793e | |
| ToppCell | ILEUM-inflamed-(7)_Endothelial_cell|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 2.82e-06 | 199 | 137 | 7 | 97052c28e354833901f28d339b09f97f50a5b752 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.91e-06 | 200 | 137 | 7 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| ToppCell | TCGA-Peripheral_Nervous_System-Primary_Tumor-Paraganglioma-Paraganglioma-3|TCGA-Peripheral_Nervous_System / Sample_Type by Project: Shred V9 | 3.89e-06 | 135 | 137 | 6 | ac20133d4a36f48338b45bffb13e842cb66f83ad | |
| ToppCell | Sigmoid-Macrophage-Macrophage|Macrophage / Region, Cell class and subclass | 1.36e-05 | 168 | 137 | 6 | bb16e135b6ae0d66615420b61edd6f62f2a3233c | |
| ToppCell | Control-Endothelial_cells-Systemic_venous_endothelial_cells|Control / group, cell type (main and fine annotations) | 1.55e-05 | 172 | 137 | 6 | c55dce1ed3ed7312394b4e050e1de852a994e130 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.89e-05 | 178 | 137 | 6 | 01dafd19de04eff459253eaa9a35debf8f3deedf | |
| ToppCell | facs-Marrow-Granulocytes-3m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.07e-05 | 181 | 137 | 6 | 566249e04dd491e6287ad2101b7b1ab11031ed8b | |
| ToppCell | facs-Marrow-Granulocytes-3m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.07e-05 | 181 | 137 | 6 | db9528dc7cb0230e4c36cb27da69102c588c7ee9 | |
| ToppCell | droplet-Spleen-SPLEEN-1m-Lymphocytic-immature_NKT_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.34e-05 | 185 | 137 | 6 | 736bf89a7a1a840ab6920060f2d98598332065a0 | |
| ToppCell | (0)_Myeloid-(011)_pDC|(0)_Myeloid / immune cells in Peripheral Blood (logTPM normalization) | 2.57e-05 | 188 | 137 | 6 | a81b5d840490d6a636fe168f8cff2c4984369f09 | |
| ToppCell | facs-Trachea-nan-3m-Endothelial|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.64e-05 | 189 | 137 | 6 | f60ac60ab9b317a0196f0cbbe520ef7dbd19ac11 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Alv_Gen_Intermediate|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.64e-05 | 189 | 137 | 6 | e82211b9dc7540e7a183be2cbcfae39fdf503949 | |
| ToppCell | facs-Trachea-nan-3m-Endothelial-endothelial_cell|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.64e-05 | 189 | 137 | 6 | e3d65417997bdd3f9c312c0977dceb6eca061029 | |
| ToppCell | facs-Trachea-nan-3m-Endothelial-nan|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.64e-05 | 189 | 137 | 6 | 5559af03d9d612bb8dcf825e45744a9f8332bac8 | |
| ToppCell | COVID-19-lung-Vein_EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.72e-05 | 190 | 137 | 6 | 1caeaef78326734c1e31a0c4739190d5c5a77b9e | |
| ToppCell | COVID-19-Endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 2.72e-05 | 190 | 137 | 6 | 9fbd92cd6d4683b2490504d29c43cf42020433d4 | |
| ToppCell | (011)_pDC|World / immune cells in Peripheral Blood (logTPM normalization) | 2.80e-05 | 191 | 137 | 6 | d82ac4f6d9863734e09bf3cb71c1354a49b66b4f | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.89e-05 | 192 | 137 | 6 | 04f5a2e3dd6beff027b89d66eefdd92036e041af | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.89e-05 | 192 | 137 | 6 | c07d7b40b2aa4eb27ac85801c014a656e2fd01dc | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-Gen_Cap|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.97e-05 | 193 | 137 | 6 | e09387af84d2a0a526e54d4793e6e06c6739db53 | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.97e-05 | 193 | 137 | 6 | 02f633b016ab19bfa65bfd0cf32f000549a62148 | |
| ToppCell | LPS-antiTNF-Endothelial|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.97e-05 | 193 | 137 | 6 | 5122b1ffba42de190061be34ecdc6176f84e56a3 | |
| ToppCell | LPS-IL1RA-Endothelial|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.06e-05 | 194 | 137 | 6 | 43f92b0533e26633dc94cce554045d641ef8fd76 | |
| ToppCell | IPF-Endothelial|IPF / Disease state, Lineage and Cell class | 3.06e-05 | 194 | 137 | 6 | 9591993aa2dcba3d09a0f1ea8b8f2439c26482d6 | |
| ToppCell | Endothelial-endothelial_cell_of_vein|World / Lineage, Cell type, age group and donor | 3.06e-05 | 194 | 137 | 6 | 3cbd9622a68e89add90e589867d88c83c5a33476 | |
| ToppCell | Fetal_29-31_weeks-Endothelial-endothelial_cell_of_vein|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.06e-05 | 194 | 137 | 6 | fc2e0081005c0c496e41197a2d06e4a37708221f | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.06e-05 | 194 | 137 | 6 | 1d39d968730a7e85b6161c1c8a6bd38afe9bcad7 | |
| ToppCell | LPS_only-Endothelial|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.06e-05 | 194 | 137 | 6 | 58f069efdefa0366033764446b9d6ffd4a17807e | |
| ToppCell | LPS_only-Endothelial-Endothelial|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.06e-05 | 194 | 137 | 6 | bfd92ec75facb0ba55c31e5f2e089d983b3d0169 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_monocytic-non-classical_monocyte-Non-classical_monocytes-Non-classical_monocytes_L.1.2.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.06e-05 | 194 | 137 | 6 | dfe0ece81922bfd7c6673726d3ea2365cbdb5513 | |
| ToppCell | IPF-Endothelial-VE_Peribronchial|World / Disease state, Lineage and Cell class | 3.15e-05 | 195 | 137 | 6 | 120296531bbc8080dcabacbd64733cc1dc34603a | |
| ToppCell | IPF-Endothelial-VE_Peribronchial|IPF / Disease state, Lineage and Cell class | 3.15e-05 | 195 | 137 | 6 | 2c3ad3cb79f11119ac69c413a938d21199145040 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Endothelial|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.24e-05 | 196 | 137 | 6 | 629236f95c838a473b5964a49b7c1b7ad863ea12 | |
| ToppCell | Endothelial|World / Lineage, Cell type, age group and donor | 3.24e-05 | 196 | 137 | 6 | 96c6d78482a130ce4e29f6629972a06d10d7530e | |
| ToppCell | nucseq-Endothelial|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.33e-05 | 197 | 137 | 6 | ebf9be068eaa658493fa7884fd19f34642922acb | |
| ToppCell | Severe_COVID-19-Epithelial-transitional_Epi|Severe_COVID-19 / Disease group,lineage and cell class （2021.01.30） | 3.33e-05 | 197 | 137 | 6 | 5ad3cd4c77016e862041baac3076f8cc0f75c417 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Endothelial|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.33e-05 | 197 | 137 | 6 | dfc052a447c3b32235fcaffdf06c4e0941723d19 | |
| ToppCell | LPS_only-Endothelial-Endothelial-FOXM1|LPS_only / Treatment groups by lineage, cell group, cell type | 3.33e-05 | 197 | 137 | 6 | 038fd92750257d43d5e980fd06d77742b543f11a | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW19-Macroglial-Astrocyte|GW19 / Sample Type, Dataset, Time_group, and Cell type. | 3.43e-05 | 198 | 137 | 6 | bfad1c51cf884ff7ce89f8278820800582541dc7 | |
| ToppCell | severe-HLA-DR+_CD83+_Monocyte|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.43e-05 | 198 | 137 | 6 | a77f3440d7fb6a50066abc7e9ad59e83798ef13d | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW19-Macroglial|GW19 / Sample Type, Dataset, Time_group, and Cell type. | 3.43e-05 | 198 | 137 | 6 | 6372e65242236c497d9b3be147092897c1609d22 | |
| ToppCell | ILEUM-inflamed-(7)_CD36+_endothelial_cells|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 3.43e-05 | 198 | 137 | 6 | 05d6558c7990ad2277db999025a073d29b273dfc | |
| ToppCell | Control_saline-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|Control_saline / Treatment groups by lineage, cell group, cell type | 3.43e-05 | 198 | 137 | 6 | 0c4d2c68a42f8a9e964e2dd28092fe75f5216834 | |
| ToppCell | Sepsis-ICU-SEP-Lymphocyte-T/NK-gd_T|ICU-SEP / Disease, condition lineage and cell class | 3.43e-05 | 198 | 137 | 6 | b40899f8f5f32420fb4574069dd7afd9e7e70d91 | |
| ToppCell | Skin-Endothelial|Skin / Skin and Kidney Cells in Lupus Nephritis Patients. | 3.53e-05 | 199 | 137 | 6 | 6b3ef5d8f87cdfe5401d05f19339ddfcd9cda476 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 3.53e-05 | 199 | 137 | 6 | 30d3e8c0681ec11f86dd38c5f48d21187a1b4f90 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Endothelial|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.53e-05 | 199 | 137 | 6 | f0bf75bfae7b288ecb6801be458b03ebd0108ea7 | |
| ToppCell | NS-moderate-d_0-4-Epithelial|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.63e-05 | 200 | 137 | 6 | 64462a18afca3c1a8548a857924b8166058bf958 | |
| ToppCell | ILEUM-non-inflamed-(7)_Endothelial_cell|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 3.63e-05 | 200 | 137 | 6 | ec92fe4eafe527d351ee73c9735e96855ac506a3 | |
| ToppCell | LPS_only-Endothelial-Endothelial-FOXM1|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.93e-05 | 134 | 137 | 5 | 4d8f7ddad02fe76a614771e115ebb8e04623ba85 | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Myeloid-Dendritic-conventional_dendritic_cell-DC_c3-LAMP3|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.05e-05 | 139 | 137 | 5 | bb2b020dda32ddc60ec9952de5b01acee60b5b59 | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal-Peri/Epineurial_-NAF_endoneurial|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 8.61e-05 | 145 | 137 | 5 | e808502fa52baf1c400f3c9b918a167127e78af9 | |
| ToppCell | Mild/Remission-B_naive-5|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 9.48e-05 | 148 | 137 | 5 | 8b60f9843505660b3c9d5c7792976f902be4b94c | |
| ToppCell | E15.5-Mesenchymal-developing_mesenchymal_cell-mesenchymal_immature_unknown_1|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.14e-04 | 154 | 137 | 5 | e65e4636646164610f33f7bbac0d879a3ea55986 | |
| ToppCell | 10x5'-Liver-Myeloid_Mac-Intestinal_macrophages|Liver / Manually curated celltypes from each tissue | 1.21e-04 | 156 | 137 | 5 | 9a897fc79c4fae94c5f2e9012d65297f9225e5e3 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Mesenchymal-fibroblastic-mLTo|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.25e-04 | 157 | 137 | 5 | c779a53b2c67d566f5d417e753cd17196a6bfd1c | |
| ToppCell | COVID_non-vent-Lymphocytic-Dendritic-pDC|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 1.37e-04 | 160 | 137 | 5 | 61f4cb4eb4313d8318aadbb99595a6cb7fd919f7 | |
| ToppCell | ICU-SEP-Lymphocyte-T_NK-gdT|ICU-SEP / Disease, Lineage and Cell Type | 1.37e-04 | 160 | 137 | 5 | 0a14b1fed54a09c0caf263662b5bd426466c7189 | |
| ToppCell | COVID_non-vent-Lymphocytic-Dendritic|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 1.37e-04 | 160 | 137 | 5 | 34b4f710cfcb6ec370b8b074f3cbfe272f392cec | |
| ToppCell | TCGA-Uterus-Primary_Tumor-Uterine_Carcinoma-Uterine_Carcinosarcoma-3|TCGA-Uterus / Sample_Type by Project: Shred V9 | 1.49e-04 | 163 | 137 | 5 | d64dd39b077105c73e570ccef70f0e74a2c586ac | |
| ToppCell | droplet-Marrow-BM-30m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.53e-04 | 164 | 137 | 5 | b77995958c938e10a526118f75d78cee72e0b207 | |
| ToppCell | Endothelial-endothelial_cell_of_bronchial_vessel|World / Lineage, Cell type, age group and donor | 1.58e-04 | 165 | 137 | 5 | 84e553d699ac56df89a77248f7308b9133e1b683 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Myeloid-Macrophage-macrophage,_alveolar|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.62e-04 | 166 | 137 | 5 | 28a44448a0b0d72459e8fe84ce5d666f16f514b3 | |
| ToppCell | TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-5|TCGA-Ovary / Sample_Type by Project: Shred V9 | 1.62e-04 | 166 | 137 | 5 | 32d2eaf8a5d03881bf74d680825af2d5110b082d | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.2.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.62e-04 | 166 | 137 | 5 | 7495961adcefe5c1fb288913b1a5236328a04703 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Myeloid-Macrophage|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.62e-04 | 166 | 137 | 5 | 2a04915d534a83e65aa168435d6856125b5bdd78 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.67e-04 | 167 | 137 | 5 | 83969c36ac44b96afc9aa09400a99fa2b487f7ff | |
| ToppCell | E16.5-Endothelial-Endothelial_lymphatic|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.67e-04 | 167 | 137 | 5 | b93103a868fba63a8910bffb690a6242b9252833 | |
| ToppCell | ICU-NoSEP-Lymphocyte-T_NK-NK_CD56bright|ICU-NoSEP / Disease, Lineage and Cell Type | 1.67e-04 | 167 | 137 | 5 | f4f188a8efca8cdd0ecfb857fe4538c10847eadd | |
| ToppCell | E16.5-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.67e-04 | 167 | 137 | 5 | fcd583b1efd0ac883379982ea8e6c54f2c0be268 | |
| ToppCell | E16.5-Endothelial-Endothelial_lymphatic-Lymphatic_EC|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.67e-04 | 167 | 137 | 5 | f6bc63138b7239211fa5f27a8dc799b6e022c0f8 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c03-GZMK|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.67e-04 | 167 | 137 | 5 | abc4ba308ca3be41b0da604f5d82579fd58dff7b | |
| ToppCell | droplet-Spleen-nan-18m-Lymphocytic-NK_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.67e-04 | 167 | 137 | 5 | aef22535a76e93472bcedacbb2c6991f3c9c8cd5 | |
| ToppCell | E16.5-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC-LEC_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.67e-04 | 167 | 137 | 5 | 26cd8ee5e826e71eaf58d10a906543a6932fb3f9 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Stem-like-OPC-like-OPC-like_Prolif-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.76e-04 | 169 | 137 | 5 | 2833a8a7094e4d407eb923f2bc59b9b112c6bae4 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-basophil|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.76e-04 | 169 | 137 | 5 | 5f5bec13208f4c3b6eacbba180c8a6402743b76e | |
| ToppCell | CV-Mild-7|CV / Virus stimulation, Condition and Cluster | 1.81e-04 | 170 | 137 | 5 | 25ebde7d2f8ae1afdfaf5876284ff20bb179eb10 | |
| ToppCell | facs|World / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.86e-04 | 171 | 137 | 5 | c9990bc041a632b2f7bbebbfe737772c423d7027 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-5w-Mesenchymal-Cilia-bearing_cell|5w / Sample Type, Dataset, Time_group, and Cell type. | 1.97e-04 | 173 | 137 | 5 | d4cbeae262abfa30d8c5452285d3261a96875610 | |
| ToppCell | CV-Mild-7|Mild / Virus stimulation, Condition and Cluster | 1.97e-04 | 173 | 137 | 5 | c9bbca9313a0fdf146c8c995624b94b937e818d8 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_1_/_Segment_2|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.97e-04 | 173 | 137 | 5 | 8888434641ea554a9b62c436e87920378eef29cd | |
| ToppCell | wk_20-22-Epithelial-Proximal_epithelial-Proximal_secretory_3|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 2.02e-04 | 174 | 137 | 5 | 9e5fae9ecc7c0111fc8a252e72b89dc89c0d3a7c | |
| ToppCell | IPF-Myeloid-pDC|World / Disease state, Lineage and Cell class | 2.08e-04 | 175 | 137 | 5 | a06785a4ded01adfd29ca4c20f7759eccbe274cb | |
| ToppCell | Control-Neuronal_cells-Neuronal_cells|Control / group, cell type (main and fine annotations) | 2.13e-04 | 176 | 137 | 5 | 98c07d26ba0dc0fe15ca0ea81f633d4591782bd1 | |
| ToppCell | Control-Neuronal_cells|Control / group, cell type (main and fine annotations) | 2.13e-04 | 176 | 137 | 5 | c29d09ecf0eb17f767d78af4b7f2e7725c967ff8 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-CD8-positive,_alpha-beta_T_cell-CD8_T_cells-CD8_T_cells_L.1.1.0.4|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.13e-04 | 176 | 137 | 5 | ce85a13e10cf37f5cf38ca8b0bac6701b6d00ffd | |
| ToppCell | Fetal_29-31_weeks-Epithelial-club_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.13e-04 | 176 | 137 | 5 | 3bbac5c2397535631fce8fa98f6ddb4fe0260351 | |
| Disease | asphyxiating thoracic dystrophy (is_implicated_in) | 3.02e-06 | 7 | 132 | 3 | DOID:0050592 (is_implicated_in) | |
| Disease | obesity (implicated_via_orthology) | 5.92e-06 | 215 | 132 | 8 | DOID:9970 (implicated_via_orthology) | |
| Disease | colorectal health | 3.52e-05 | 201 | 132 | 7 | EFO_0008460 | |
| Disease | cholesterol to total lipids in chylomicrons and extremely large VLDL percentage | 5.68e-05 | 17 | 132 | 3 | EFO_0022232 | |
| Disease | Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative | 5.94e-05 | 3 | 132 | 2 | C1292772 | |
| Disease | cholesteryl esters to total lipids in chylomicrons and extremely large VLDL percentage | 1.10e-04 | 21 | 132 | 3 | EFO_0022246 | |
| Disease | sortilin measurement | 1.18e-04 | 4 | 132 | 2 | EFO_0600000 | |
| Disease | Ciliopathies | 1.40e-04 | 110 | 132 | 5 | C4277690 | |
| Disease | JOUBERT SYNDROME 17 | 1.97e-04 | 5 | 132 | 2 | C3553264 | |
| Disease | migraine disorder, pulse pressure measurement | 2.11e-04 | 26 | 132 | 3 | EFO_0005763, MONDO_0005277 | |
| Disease | Familial aplasia of the vermis | 3.25e-04 | 30 | 132 | 3 | C0431399 | |
| Disease | Disorder of eye | 3.96e-04 | 212 | 132 | 6 | C0015397 | |
| Disease | cancer antigen 15.3 measurement | 4.11e-04 | 7 | 132 | 2 | EFO_0010585 | |
| Disease | LDL cholesterol change measurement | 4.11e-04 | 7 | 132 | 2 | EFO_0007804 | |
| Disease | OROFACIODIGITAL SYNDROME VI | 4.11e-04 | 7 | 132 | 2 | C2745997 | |
| Disease | chylomicron measurement, triglycerides:total lipids ratio, very low density lipoprotein cholesterol measurement | 4.73e-04 | 34 | 132 | 3 | EFO_0008317, EFO_0008596, EFO_0020947 | |
| Disease | marginal zone B-cell lymphoma | 5.46e-04 | 8 | 132 | 2 | EFO_1000630 | |
| Disease | esterified cholesterol measurement, intermediate density lipoprotein measurement | 5.46e-04 | 8 | 132 | 2 | EFO_0008589, EFO_0008595 | |
| Disease | triglyceride change measurement, response to long-chain n-3 PUFA dietary supplementation | 5.46e-04 | 8 | 132 | 2 | EFO_0007681, EFO_0009308 | |
| Disease | NEPHRONOPHTHISIS 2 | 5.46e-04 | 8 | 132 | 2 | C1865872 | |
| Disease | pulse pressure measurement, migraine without aura, susceptibility to, 4 | 7.00e-04 | 9 | 132 | 2 | EFO_0005763, MONDO_0011847 | |
| Disease | bringing up phlegm, sputum or mucus on most days, self-reported | 7.00e-04 | 9 | 132 | 2 | EFO_0009824 | |
| Disease | Spastic Paraplegia | 7.00e-04 | 9 | 132 | 2 | C0037772 | |
| Disease | triglycerides to total lipids in large VLDL percentage | 7.11e-04 | 39 | 132 | 3 | EFO_0022332 | |
| Disease | myocardial infarction (is_implicated_in) | 1.04e-03 | 99 | 132 | 4 | DOID:5844 (is_implicated_in) | |
| Disease | Posterior Choroidal Artery Infarction | 1.06e-03 | 11 | 132 | 2 | C0887799 | |
| Disease | Cerebral Infarction, Left Hemisphere | 1.06e-03 | 11 | 132 | 2 | C0751010 | |
| Disease | Anterior Choroidal Artery Infarction | 1.06e-03 | 11 | 132 | 2 | C0751012 | |
| Disease | Cerebral Infarction, Right Hemisphere | 1.06e-03 | 11 | 132 | 2 | C0751011 | |
| Disease | Subcortical Infarction | 1.06e-03 | 11 | 132 | 2 | C0751014 | |
| Disease | Cerebral Infarction | 1.06e-03 | 11 | 132 | 2 | C0007785 | |
| Disease | blood cobalt measurement | 1.12e-03 | 101 | 132 | 4 | EFO_0007577 | |
| Disease | Liver Cirrhosis | 1.20e-03 | 103 | 132 | 4 | C0023890 | |
| Disease | dementia (is_implicated_in) | 1.27e-03 | 12 | 132 | 2 | DOID:1307 (is_implicated_in) | |
| Disease | Fibrosis, Liver | 1.29e-03 | 105 | 132 | 4 | C0239946 | |
| Disease | – | 1.50e-03 | 13 | 132 | 2 | 608446 | |
| Disease | Myocardial infarction, susceptibility to | 1.50e-03 | 13 | 132 | 2 | cv:C1832662 | |
| Disease | respiratory quotient | 1.74e-03 | 14 | 132 | 2 | EFO_0005189 | |
| Disease | esterified cholesterol measurement, low density lipoprotein cholesterol measurement | 1.74e-03 | 14 | 132 | 2 | EFO_0004611, EFO_0008589 | |
| Disease | antihyperlipidemic drug use measurement | 1.80e-03 | 115 | 132 | 4 | EFO_0803367 | |
| Disease | Polydactyly | 1.92e-03 | 117 | 132 | 4 | C0152427 | |
| Disease | triglycerides to total lipids in chylomicrons and extremely large VLDL percentage | 2.01e-03 | 15 | 132 | 2 | EFO_0022328 | |
| Disease | Hypertriglyceridemia | 2.01e-03 | 15 | 132 | 2 | C0020557 | |
| Disease | response to statin, LDL cholesterol change measurement | 2.01e-03 | 15 | 132 | 2 | EFO_0007804, GO_0036273 | |
| Disease | obsolete aging, cognition | 2.01e-03 | 15 | 132 | 2 | EFO_0003925, GO_0007568 | |
| Disease | cholesteryl esters to total lipids in large VLDL percentage | 2.04e-03 | 56 | 132 | 3 | EFO_0022250 | |
| Disease | Alzheimer's disease (implicated_via_orthology) | 2.15e-03 | 57 | 132 | 3 | DOID:10652 (implicated_via_orthology) | |
| Disease | low density lipoprotein particle size measurement | 2.26e-03 | 58 | 132 | 3 | EFO_0008593 | |
| Disease | response to antineoplastic agent, response to antimicrotubule agent | 2.29e-03 | 16 | 132 | 2 | EFO_0005260, GO_0097327 | |
| Disease | Malignant neoplasm of skin | 2.37e-03 | 59 | 132 | 3 | C0007114 | |
| Disease | Skin Neoplasms | 2.37e-03 | 59 | 132 | 3 | C0037286 | |
| Disease | melanoma | 2.51e-03 | 126 | 132 | 4 | EFO_0000756 | |
| Disease | age at diagnosis, type 1 diabetes mellitus | 2.73e-03 | 62 | 132 | 3 | EFO_0004918, MONDO_0005147 | |
| Disease | coronary artery disease, plasminogen activator inhibitor 1 measurement | 2.86e-03 | 63 | 132 | 3 | EFO_0001645, EFO_0004792 | |
| Disease | ischemia (biomarker_via_orthology) | 2.90e-03 | 18 | 132 | 2 | DOID:326 (biomarker_via_orthology) | |
| Disease | very low density lipoprotein cholesterol measurement, esterified cholesterol measurement | 2.90e-03 | 18 | 132 | 2 | EFO_0008317, EFO_0008589 | |
| Disease | neck circumference | 3.23e-03 | 19 | 132 | 2 | EFO_0011043 | |
| Disease | hydrocephalus (implicated_via_orthology) | 3.23e-03 | 19 | 132 | 2 | DOID:10908 (implicated_via_orthology) | |
| Disease | sodium-coupled monocarboxylate transporter 1 measurement | 3.23e-03 | 19 | 132 | 2 | EFO_0802076 | |
| Disease | Malignant neoplasm of breast | DYNC2H1 NSD2 SYNE1 TECTA MFGE8 SLC39A12 THBS3 OTOGL AHR NOTCH2 ZNF541 NOTCH4 | 3.25e-03 | 1074 | 132 | 12 | C0006142 |
| Disease | Familial aplasia of the vermis | 3.58e-03 | 20 | 132 | 2 | cv:C0431399 | |
| Disease | Joubert syndrome 1 | 3.94e-03 | 21 | 132 | 2 | C4551568 | |
| Disease | saturated fatty acids to total fatty acids percentage | 3.94e-03 | 21 | 132 | 2 | EFO_0022305 | |
| Disease | tissue plasminogen activator measurement, coronary artery disease | 4.01e-03 | 71 | 132 | 3 | EFO_0001645, EFO_0004791 | |
| Disease | hip circumference | 4.23e-03 | 338 | 132 | 6 | EFO_0005093 | |
| Disease | breast cancer, COVID-19 | 4.33e-03 | 22 | 132 | 2 | MONDO_0007254, MONDO_0100096 | |
| Disease | migraine disorder, endometriosis | 4.33e-03 | 73 | 132 | 3 | EFO_0001065, MONDO_0005277 | |
| Disease | body weight | ZFAT ZNF423 AOAH ZNF521 CHN2 TRIM24 SLIT2 NELL1 EYS AATK HACE1 TLN2 UNC79 | 4.36e-03 | 1261 | 132 | 13 | EFO_0004338 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| ISCNQPVLPQHSKCT | 701 | P35869 | |
| SLNTDKTLCQPNEHN | 46 | Q7Z3E2 | |
| FFLQCISCHPNNQKL | 3766 | Q9NR09 | |
| QDLKTHQRLPCCSHL | 71 | Q2NKJ3 | |
| GIHQSQDALCTCPKL | 941 | Q8N157 | |
| PSCECHLNNLSQSVN | 131 | Q5T601 | |
| NASLAQHSEVKPCTC | 701 | Q86TB3 | |
| VKPNSNQVNLASCCV | 181 | P48507 | |
| CNNLQCGSFLKHLPE | 201 | P06127 | |
| KPLCSSNGSHINCVN | 1446 | Q86UQ4 | |
| LQKHCCILPDRNTES | 11 | Q9P1A6 | |
| LHLATISCQPQCVKV | 91 | Q8N283 | |
| ISCQPQCVKVLLQHG | 96 | Q8N283 | |
| CPAKKNVCDSNTCHN | 1571 | Q9HCU4 | |
| TKLGSLHPQSLNCQC | 1091 | Q96M86 | |
| GHPQCLKQLLQASCV | 126 | Q8TF21 | |
| VVCNHCSQVVKPQAF | 81 | Q5T6C5 | |
| HNCEIVNKPPSVIQC | 1396 | P59510 | |
| LLILCCQTQGENHPS | 16 | O60258 | |
| LNCKQNCVTELASHP | 276 | Q32P28 | |
| NHVVQKCIECVQPQS | 851 | Q8TB72 | |
| CHSKNNSPQDLETQL | 281 | Q9UFC0 | |
| LEFCKQNTGQPLCHL | 111 | P28039 | |
| GQNSKCLHCISVSPI | 731 | Q8TAB3 | |
| HSDPCQNDATCLDKI | 461 | Q04721 | |
| LNIGIPSLTKCCNQH | 96 | Q9BZM1 | |
| SLAAQNICTSKLHCP | 76 | Q96RG2 | |
| ICILSHPIKNTNDAN | 301 | P50395 | |
| NLCDLLHNPCRNNST | 851 | Q5T1H1 | |
| LHNPCRNNSTCLALV | 856 | Q5T1H1 | |
| NCETNLNKHIVPDCL | 926 | Q8IV33 | |
| VHQQLCSVNSQLEPC | 241 | Q8N9B5 | |
| LVALDICSKNPCHNG | 21 | Q08431 | |
| NTHLCDLNSTQCVPL | 291 | Q6PRD1 | |
| HVCLPSQFKCTNTNR | 3411 | Q07954 | |
| SPVVFCHNDLLCKNI | 241 | Q9NVF9 | |
| TNCQCQAPHEKLTIA | 51 | Q9Y5K3 | |
| NTLLNVIACTHVPCN | 4956 | Q02817 | |
| QGLCKCLPANVHQLI | 96 | Q9NST1 | |
| NHSCQPNCETLKWTV | 1141 | O96028 | |
| ACQNGHKTTVQCLLD | 171 | Q8IYU2 | |
| AVSVHCSNPCENILN | 491 | Q12986 | |
| QNHSCSKSSEDLKPC | 461 | Q6ZU52 | |
| SVADPHNLKICCRVN | 226 | Q96GK7 | |
| PHCTQATLCALIQEK | 1091 | Q9UKK3 | |
| REQICKQSPSCVLHL | 81 | Q9P2E7 | |
| CSHPQELQELCQSTL | 726 | P78316 | |
| CDIAPLLQVACINTH | 176 | Q8NGM8 | |
| TPQDSLAQCKELQDH | 1776 | P42694 | |
| CVECLLLHSGKPDNQ | 641 | P18084 | |
| CSNFLIKQLHPSNCL | 271 | Q9C0H6 | |
| LNCSEKDHILPENQC | 371 | Q92832 | |
| QCTLSDQLLPKHCAK | 621 | Q9Y2A7 | |
| CNNIHCLAKAINQIA | 1026 | Q9Y2A7 | |
| NHVVQKCIECVQPQS | 971 | Q14671 | |
| SIHPQLIKNFHQCCL | 826 | Q9ULD6 | |
| NVHKQCSKHVPNDCQ | 251 | P52757 | |
| INCESNPALHKKCQV | 2791 | Q8NCM8 | |
| NVSIHLKNPENCSCQ | 411 | Q8N4S0 | |
| ALVQCGQPQCSTHIL | 381 | P04114 | |
| SVQCLTNEDQPSHLC | 1701 | Q9P2N4 | |
| AEKLHTQPSCPAVCQ | 31 | P83105 | |
| ACNQQLTAKLACPRH | 56 | Q14674 | |
| CTPHNTKTIQAEFQC | 301 | P48745 | |
| TQPCHHQARKSCLQC | 736 | P41002 | |
| QQDCHLCSLIPKCES | 236 | Q9H799 | |
| SVADPHNLKICCRVN | 226 | Q6P2I3 | |
| CPNCTILQVQDETHS | 316 | Q9BTC0 | |
| NCEKLQSVCSDIFPH | 256 | P21554 | |
| CHILINNPINACELS | 386 | O43303 | |
| PITASCIIKQNCSHL | 41 | Q99062 | |
| CIIKQNCSHLDPEPQ | 46 | Q99062 | |
| VCSHHNQCLPQDVLQ | 761 | Q99698 | |
| THPSLISNLPNCCKE | 356 | Q69YH5 | |
| ICILSHPIKNTNDAN | 301 | P31150 | |
| PNKHSRACQQFLKQC | 96 | Q6UXB2 | |
| GSPVVLCHNDLLCKN | 301 | Q9HBU6 | |
| QTHVENQSANCLKSC | 436 | Q99590 | |
| RVQHSCPICQKKFTN | 736 | Q9BXA9 | |
| IQQLLSCSCHLPKDQ | 341 | Q504Y0 | |
| SCSCHLPKDQQAKLP | 346 | Q504Y0 | |
| ILHNNPSSQRALCLC | 216 | Q7RTP0 | |
| QVFLKPCSHVVSCQQ | 91 | O43933 | |
| CVLAIKHCNQEQDCP | 311 | Q14114 | |
| QELHLCHCPAKVEQT | 516 | Q7L1W4 | |
| NSQKLIVGHSPLSCC | 1951 | Q3ZCN5 | |
| VINHCFCDLQPLLKQ | 171 | Q8NGL9 | |
| SNRCPKCNIVVHQTQ | 166 | Q9BYE7 | |
| LSHRCKCSFNQKPQD | 56 | P58550 | |
| KQPLVLPCTHNVCQA | 41 | Q7Z4K8 | |
| SNELHQVPSNCDCLN | 21 | P00749 | |
| GHNQNCDCSPDITLK | 441 | Q8TEL6 | |
| QHLCALEQALCKQQT | 7331 | Q8NF91 | |
| VQLECSLHNKVCQQL | 231 | A2VDJ0 | |
| KHSNLLQCLAQCAEV | 181 | Q6ZMQ8 | |
| HPDCAQSLNNLAALC | 1131 | Q7Z494 | |
| ILCQALENPNCNLKH | 921 | Q8WX94 | |
| SQAACQCSHQPSKVE | 151 | Q2KHM9 | |
| SKELDACQSQPCHNH | 966 | Q99466 | |
| LCNPDFCQRIQSQLH | 441 | Q9NRP7 | |
| CNQDHCNKIELPTTV | 101 | P36897 | |
| CTNNLPKAHTCFNRI | 706 | Q9HAU4 | |
| CSLIPNQNAAFSKCH | 1301 | O75443 | |
| CAVCHQNIQSRAPKL | 56 | O15164 | |
| HQQLQKNCLLSLCSD | 421 | Q9C0D3 | |
| CPQCKQHREASKQLL | 1081 | O94966 | |
| KANNPNHCNCIIDQI | 286 | Q9UPT9 | |
| QKHSNILLKCPTDGC | 791 | Q9P243 | |
| RCSNLVLCQHIPKAE | 291 | Q53GI3 | |
| KLCENSDPTNVLSCH | 141 | Q13107 | |
| PCADNSLCVKLHNTS | 181 | Q9H3R2 | |
| VASSLKCPDACNAQH | 361 | Q9H3R2 | |
| TQHPNKPHCALASCQ | 41 | Q7Z6I5 | |
| LKILCQDNPSHNVFC | 16 | P50453 | |
| LCLPCSNSQEHRNHI | 111 | Q9BSJ1 | |
| KEIHDQNCPLANVIC | 201 | Q9Y4K3 | |
| PNAQVACDHCLKEAA | 101 | Q14258 | |
| HLDTVLPKLTCPQCN | 656 | Q96K83 | |
| PVQSINAHPSNCICI | 216 | Q96J01 | |
| LHPSCLSVCNVTIQD | 361 | Q7Z5K2 | |
| TCQHPCQDKCLVQAQ | 36 | Q5T870 | |
| NITKCLPQLLHCNGV | 36 | Q9HBX9 | |
| AQDLNPCQHDSKCIL | 1041 | O94813 | |
| KHCKQDNCLLTPNSG | 476 | P49746 | |
| CHLKATEASQNPCVR | 706 | Q3C1V9 | |
| CLQKLLQYNCPTEHA | 116 | Q9BZF9 | |
| QPTCCRKSDFTKHQQ | 261 | Q9BY31 | |
| HNCNSCGKNLEPIIT | 176 | Q5JVG2 | |
| AKAVSHSLNNCVNCL | 1191 | Q9Y4G6 | |
| QAELQDEPKHANCCT | 1156 | Q9UL36 | |
| SPNGTLEECQHQTKC | 171 | Q92956 | |
| AQCLQVQNVLSLCHT | 101 | Q6ZSB9 | |
| IHQCQHTNEPLFKCT | 151 | Q92664 | |
| CLQKCNVPLFVQHDA | 126 | Q9UMW8 | |
| HPQLSEKADLQCIHC | 286 | Q2M1K9 | |
| QNVKHNLCSNACLSK | 206 | Q5SVZ6 | |
| ANLSPQNLISCCAKN | 266 | Q9UJW2 | |
| RTEQCPLFVQHKCTQ | 41 | Q9C0B0 | |
| CNPQDLHNLTVAATK | 181 | P41732 | |
| SLNPQKWHCVDCNTT | 21 | Q9H0E7 | |
| PHLASSQKQPQKCCL | 186 | Q9Y473 | |
| QHSSPQNPLLDCSLC | 131 | Q9H0D2 | |
| CQHIECHNAINKPAV | 306 | Q9P2D8 | |
| HLIVTACTCQNNINK | 216 | P24723 |